Skopos Labs, Inc. Lantheus Holdings, Inc. Transaction History
Skopos Labs, Inc.
- $330 Million
- Q4 2024
A detailed history of Skopos Labs, Inc. transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 77 shares of LNTH stock, worth $7,043. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77Holding current value
$7,043% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LNTH
# of Institutions
542Shares Held
68MCall Options Held
679KPut Options Held
423K-
Black Rock Inc. New York, NY8.6MShares$786 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.42MShares$679 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.59MShares$328 Million0.21% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.96MShares$270 Million1.63% of portfolio
-
State Street Corp Boston, MA2.52MShares$230 Million0.01% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $6.29B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...